Placebo matching with 12.5mg
Sponsors
Sk Life Science Inc.
Conditions
Primary Generalized Tonic-Clonic Seizures
Phase 3
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
RecruitingCTIS2023-506688-32-00
Start: 2019-10-09Target: 77Updated: 2025-12-10
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
CompletedCTIS2023-506687-13-00
Start: 2019-01-31End: 2025-05-26Target: 84Updated: 2025-04-02